INSP - Inspire Medical Systems, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue50,59328,56716,4278,012
Cost of Revenue10,0566,0183,9052,809
Gross Profit40,53722,54912,5225,203
Operating Expenses
Research Development7,3886,1947,0917,079
Selling General and Administrative53,52732,35822,68417,922
Non Recurring----
Others----
Total Operating Expenses70,97144,57033,68027,810
Operating Income or Loss-20,378-16,003-17,253-19,798
Income from Continuing Operations
Total Other Income/Expenses Net-1,450-1,508-1,275-1,539
Earnings Before Interest and Taxes-20,378-16,003-17,253-19,798
Interest Expense-3,304-1,753-1,303-1,564
Income Before Tax-21,828-17,511-18,528-21,337
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-21,828-17,511-18,528-21,337
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-21,828-17,511-18,528-21,337
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-21,828-17,511-18,528-21,337